Breaking News, Promotions & Moves

Matica Biotech Names Dr. Yun Jeong Song as CEO

Song's background spans more than 20 years of basic research, patient care and biopharmaceutical industry leadership.

Author Image

By: Charlie Sternberg

Associate Editor

Matica Biotechnology Inc.’s board of directors has appointed Yun Jeong Song, MD, as the company’s new chief executive officer to continue its expansion as a CDMO supporting the global cell and gene therapy industry.   Experience   Song joined the company effective April 1, 2021 after 3 years as CEO of ImmuneOncia Therapeutics, an international joint venture developing immuno-oncology therapies. She succeeds Byung Se So, PhD, who will remain with Matica Bio as an advisor.   Song’s bac...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters